Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q4 2025 | -42.35% |
| Q3 2025 | -12.11% |
| Q2 2025 | -50.91% |
| Q1 2025 | 13.39% |
| Q4 2024 | 23.97% |
| Q3 2024 | -19.14% |
| Q2 2024 | -10.08% |
| Q1 2024 | -6.53% |
| Q4 2023 | 1.44% |
| Q3 2023 | -39.45% |
| Q2 2023 | -11.62% |
| Q1 2023 | -25.55% |
| Q4 2022 | -31.13% |
| Q3 2022 | -13.10% |
| Q2 2022 | -40.42% |
| Q1 2022 | -48.33% |
| Q4 2021 | -5.35% |
| Q3 2021 | -27.55% |
| Q2 2021 | -26.70% |
| Q1 2021 | -6.85% |
| Q4 2020 | 14.38% |
| Q3 2020 | -1.02% |
| Q2 2020 | -68.32% |
| Q1 2020 | 150.74% |
| Q4 2019 | 526.14% |
| Q3 2019 | -70.43% |
| Q2 2019 | -71.02% |
| Q1 2019 | -42.39% |
| Q4 2018 | -46.63% |
| Q3 2018 | -23.05% |
| Q2 2018 | -65.23% |
| Q1 2018 | 45.97% |
| Q4 2017 | -51.00% |
| Q3 2017 | -69.02% |
| Q2 2017 | -60.81% |
| Q1 2017 | -35.98% |
| Q4 2016 | -32.16% |
| Q3 2016 | -47.97% |
| Q2 2016 | -71.29% |
| Q1 2016 | -29.93% |